C12Y 306/03
Acting on acid anhydrides
Official title: acting on acid anhydrides; catalysing transmembrane movement of substances (3.6.3)
C12Y306/03 (Acting on acid anhydrides) appears on 81 US grants and 134 published applications in this corpus.
Search patents in C12Y- Granted patents
- 81
- Published applications
- 134
- Assignees
- 98
- Inventors
- 293
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 3 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 4 |
| 2007 | 1 | 1 |
| 2008 | 0 | 6 |
| 2009 | 3 | 3 |
| 2010 | 1 | 4 |
| 2011 | 1 | 3 |
| 2012 | 4 | 5 |
| 2013 | 1 | 7 |
| 2014 | 4 | 4 |
| 2015 | 7 | 15 |
| 2016 | 4 | 7 |
| 2017 | 7 | 17 |
| 2018 | 3 | 8 |
| 2019 | 8 | 2 |
| 2020 | 5 | 12 |
| 2021 | 10 | 5 |
| 2022 | 6 | 8 |
| 2023 | 3 | 2 |
| 2024 | 3 | 5 |
| 2025 | 4 | 6 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 306/03009Na+/k+-exchanging atpase14
- C12Y 306/03014H+-transporting two-sector atpase , i.e. f1 atpase13
- C12Y 306/03008Ca2+-transporting atpase12
- C12Y 306/03044Xenobiotic-transporting atpase7
- C12Y 306/03049Channel-conductance-controlling atpase7
- C12Y 306/03018Oligosaccharide-transporting atpase6
- C12Y 306/03004Cu2+-exporting atpase5
- C12Y 306/0301H+/k+-exchanging atpase5
All 51 subgroupsShow fewer
- C12Y 306/03001Phospholipid-translocating atpase , i.e. mg2+-atpase4
- C12Y 306/03005Zn2+-exporting atpase1
- C12Y 306/03016Arsenite-transporting atpase1
- C12Y 306/03002Mg2+-importing atpase0
- C12Y 306/03003Cd2+-exporting atpase0
- C12Y 306/03006H+-exporting atpase0
- C12Y 306/03007Na+-exporting atpase0
- C12Y 306/03011Cl--transporting atpase0
- C12Y 306/03012K+-transporting atpase0
- C12Y 306/03015Na+-transporting two-sector atpase0
- C12Y 306/03017Monosaccharide-transporting atpase0
- C12Y 306/03019Maltose-transporting atpase0
- C12Y 306/0302Glycerol-3-phosphate-transporting atpase0
- C12Y 306/03021Polar-amino-acid-transporting atpase0
- C12Y 306/03022Nonpolar-amino-acid-transporting atpase0
- C12Y 306/03023Oligopeptide-transporting atpase0
- C12Y 306/03024Nickel-transporting atpase0
- C12Y 306/03025Sulfate-transporting atpase0
- C12Y 306/03026Nitrate-transporting atpase0
- C12Y 306/03027Phosphate-transporting atpase0
- C12Y 306/03028Phosphonate-transporting atpase0
- C12Y 306/03029Molybdate-transporting atpase0
- C12Y 306/0303Fe3+-transporting atpase0
- C12Y 306/03031Polyamine-transporting atpase0
- C12Y 306/03032Quaternary-amine-transporting atpase0
- C12Y 306/03033Vitamin b12-transporting atpase0
- C12Y 306/03034Iron-chelate-transporting atpase0
- C12Y 306/03035Manganese-transporting atpase0
- C12Y 306/03036Taurine-transporting atpase0
- C12Y 306/03037Guanine-transporting atpase0
- C12Y 306/03038Capsular-polysaccharide-transporting atpase0
- C12Y 306/03039Lipopolysaccharide-transporting atpase0
- C12Y 306/0304Teichoic-acid-transporting atpase0
- C12Y 306/03041Heme-transporting atpase0
- C12Y 306/03042Beta-glucan-transporting atpase0
- C12Y 306/03043Peptide-transporting atpase0
- C12Y 306/03046Cadmium-transporting atpase0
- C12Y 306/03047Fatty-acyl-coa-transporting atpase0
- C12Y 306/03048Alpha-factor-transporting atpase0
- C12Y 306/0305Protein-secreting atpase0
- C12Y 306/03051Mitochondrial protein-transporting atpase0
- C12Y 306/03052Chloroplast protein-transporting atpase0
- C12Y 306/03053Ag+-exporting atpase0
Recent patents
- Peptide antigens and uses thereof16 Jun 2026US 12,653,873 B2Humanitas Mirasole S.P.A.
- CFTR mRNA compositions and related methods and uses7 Apr 2026US 12,594,295 B2ethris GmbH
- Therapy for erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP)20 Jan 2026US 12,528,808 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Methods of determining pH and calcium or chloride concentration in samples7 Oct 2025US 12,436,156 B2The University of Chicago
- Oligosaccharide production in yeast cells expressing an ABC transporter protein15 Jul 2025US 12,359,234 B2Amyris, Inc.
- Novel abc transporter permease variant and method for producing 5’-inosinic acid using same1 Oct 2026US 2026/0297640 A1Daesang Corporation
- 5'-utr variant sequences and use thereof20 Aug 2026US 2026/0242836 A1Cj Cheiljedang Corporation
- Manipulating golgi ions for treatment of neurodegenerative disease and cutaneous disorders18 Jun 2026US 2026/0166178 A1Formation Venture Engineering Foundry, Inc.
- Oligosaccharide production in yeast12 Mar 2026US 2026/0071245 A1Amyris, Inc.
- Compositions and methods for treating stargardt disease5 Mar 2026US 2026/0062704 A1Beam Therapeutics Inc.
Most cited
By later US patents
- Pancreatic cancer targets and uses thereof104US 7,473,531 B1Colora Corporation · 2009
- CFTR mRNA compositions and related methods and uses44US 9,181,321 B2ethris GmbH · 2015
- RNAi-mediated inhibition of ocular targets15US 7,592,324 B2Alcon Inc. · 2009
- Biosynthesis of human milk oligosaccharides in engineered bacteria15US 9,453,230 B2Glycosyn LLC · 2016
- CFTR mRNA compositions and related methods and uses15US 9,713,626 B2ethris GmbH · 2017